Peptide and nonpeptide antagonist interaction with constitutively active human AT1 receptors (Q42439737)

31 October 2017

title

Peptide and nonpeptide antagonist interaction with constitutively active human AT1 receptors (English)

1 reference

31 October 2017

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(03)00072-8

24 December 2023

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(03)00072-8

24 December 2023

5

Veerle Kersemans

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12694873

24 December 2023

author name string

Minh Tam Le

1

1 reference

31 October 2017

Márta Szaszák

3

1 reference

31 October 2017

László Hunyady

4

1 reference

31 October 2017

Georges Vauquelin

6

1 reference

31 October 2017

Patrick M. L. Vanderheyden

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12694873

24 December 2023

language of work or name

English

0 references

publication date

1 April 2003

1 reference

31 October 2017

15 April 2003

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12694873

full work available at URL

24 December 2023

https://api.elsevier.com/content/article/PII:S0006295203000728?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(03)00072-8

https://api.elsevier.com/content/article/PII:S0006295203000728?httpAccept=text/plain

24 December 2023

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(03)00072-8

24 December 2023

published in

Biochemical Pharmacology

1 reference

31 October 2017

volume

65

1 reference

31 October 2017

issue

8

1 reference

31 October 2017

page(s)

1329-1338

1 reference

Angiotensin II receptor antagonists

31 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900072-8

Distinction between surmountable and insurmountable selective AT1 receptor antagonists by use of CHO-K1 cells expressing human angiotensin II AT1 receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900072-8

Insurmountable angiotensin AT1 receptor antagonists: the role of tight antagonist binding

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900072-8

A two-state receptor model for the interaction between angiotensin II type 1 receptors and non-peptide antagonists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900072-8

Angiotensin IV is a potent agonist for constitutive active human AT1 receptors. Distinct roles of the N-and C-terminal residues of angiotensin II during AT1 receptor activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900072-8

Interaction of Phe8 of angiotensin II with Lys199 and His256 of AT1 receptor in agonist activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900072-8

Lys(199) mutation of the human angiotensin type 1 receptor differentially affects the binding of surmountable and insurmountable non-peptide antagonists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900072-8

The active state of the AT1 angiotensin receptor is generated by angiotensin II induction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900072-8

The conformational change responsible for AT1 receptor activation is dependent upon two juxtaposed asparagine residues on transmembrane helices III and VII.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900072-8

Mutation of Asn111 in the third transmembrane domain of the AT1A angiotensin II receptor induces its constitutive activation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900072-8

Role of aromaticity of agonist switches of angiotensin II in the activation of the AT1 receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900072-8

Constitutively active mutants of rhodopsin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900072-8

Structural basis of beta-adrenergic receptor function.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900072-8

Constitutive activation of the human bradykinin B2 receptor induced by mutations in transmembrane helices III and VI.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900072-8

A point mutation that confers constitutive activity to CXCR4 reveals that T140 is an inverse agonist and that AMD3100 and ALX40-4C are weak partial agonists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900072-8

Alanine exchanges of polar amino acids in the transmembrane domains of a platelet-activating factor receptor generate both constitutively active and inactive mutants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900072-8

Polar residues in the transmembrane domains of the type 1 angiotensin II receptor are required for binding and coupling. Reconstitution of the binding site by co-expression of two deficient mutants.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900072-8

Amino acids of the third transmembrane domain of the AT1A angiotensin II receptor are involved in the differential recognition of peptide and nonpeptide ligands

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900072-8

Interaction of biphenylimidazole and imidazoleacrylic acid nonpeptide antagonists with valine 108 in TM III of the AT1 angiotensin receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900072-8

Role of basic amino acids of the human angiotensin type 1 receptor in the binding of the non-peptide antagonist candesartan

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900072-8

Mutagenesis and the molecular modeling of the rat angiotensin II receptor (AT1)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900072-8

Differentiation between binding sites for angiotensin II and nonpeptide antagonists on the angiotensin II type 1 receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900072-8

Dependence of AT1 angiotensin receptor function on adjacent asparagine residues in the seventh transmembrane helix

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900072-8

Reversible and syntopic interaction between angiotensin receptor antagonists on Chinese hamster ovary cells expressing human angiotensin II type 1 receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900072-8

The docking of Arg2 of angiotensin II with Asp281 of AT1 receptor is essential for full agonism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900072-8

Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900072-8

International union of pharmacology. XXIII. The angiotensin II receptors

7 January 2021

1

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(03)00072-8

24 December 2023

Identifiers

1 reference

31 October 2017

1 reference